期刊文献+

裂解型腺病毒Ad-E1A对人脐静脉内皮细胞的影响 被引量:3

The Effect of Oncolytic Adenovirus on Human Umbilical Vein Endothelial Cell
下载PDF
导出
摘要 以QBI-293A细胞基因组DNA为模板,PCR扩增E1A基因,酶切连接到pAdTrack-CMV转移质粒上,pAdTrack-CMV-E1A经PmeI线性化后,与pAdEasy-1共转化大肠杆菌BJ5183,筛选重组腺病毒质粒pAdEasy-1-pAdTrack-CMV-E1A,经PacI线性化,脂质体转染QBI-293A细胞,获得裂解型腺病毒Ad-E1A。裂解型腺病毒Ad-E1A在ECV304细胞内复制裂解,抑制细胞的生长,并可以降低VEGF的表达,探讨了Ad-E1A可能通过抑制ECV304细胞NF-κB的激活而引起细胞生长抑制的机制,说明Ad-E1A具有抑制肿瘤转移的功能。 The E1A gene was obtained by PCR with QBI-293A cell genome DNA as template. After enzyme digestion, the E1A gene was ligated to transfer vector pAdTrack-CMV. The positive clone pAdTrack-CMV-E1A were lineared by PmeI and cotransformed with pAdEasy-1 in BJ5183 E. coli. The recombinant adenovirus vector pAdEasy-1-pAdTrack-CMV-E1A were digested by PacI and transfected into QBI-293A cells with liposomes. The oncolytic recombinant adenovirns Ad-E1A was obtained after 7 days. The results showed that this oncolytic adenovirns Ad-E1A can replicate in ECV304 cells and inhibit growth of ECV304 cell. In addition, it also decreased the secretion of VEGF and expression of NF-kB of ECV304 cells, indicating that AdE1A have potential of inhibition of tumor metastasis.
出处 《生物工程学报》 CAS CSCD 北大核心 2006年第3期397-402,共6页 Chinese Journal of Biotechnology
基金 苏州大学医学发展基金资助项目(No.EE134517)~~
关键词 裂解型腺病毒 Ad-E1A 人脐静脉内皮细胞 oncolytic adenovirus, Ad-E1A, human umbilical vein endothelial cell
  • 相关文献

参考文献1

二级参考文献10

  • 1Khuri FR,Nemunaitis J,Ganly I,et al.A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer[].Nature Medicine.2000
  • 2Khuri FR,Nemunaitis J,Ganly I,et al.A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer[].Nature Medicine.2000
  • 3Heise C,Kim DH.Replication-selective adenoviruses as onco lytic agents[].The Journal of Clinical Investigation.2000
  • 4Heise CC,Williams AM,Xue S,Propst M,Kirn DH.Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy[].Cancer Research.1999
  • 5Goodrum FD,Ornelles DA.The early region1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle[].Journal of Virology.1997
  • 6Wildner O,Morris JC.The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus tk: assessment of antitumor efficacy and toxicity[].Cancer Research.2000
  • 7Hawkins LK,Johnson L,Bauzon M,et al.Gene delivery from the E3 region of replicating human adenovirus: Evaluation of the 6. 7K/gp 19K region[].Gene Therapy.2001
  • 8Gomez-Navarro J,Curiel DT.Conditionally replicative adeno viral vectors for cancer gene therapy[].The Lancet Oncology.2000
  • 9Shinoura N,Yoshida Y,Tsunoda R,et al.Highly augmented cytopathic effect of a fiber-mutant E1 B-defective adenovirus for gene therapy of gliomas[].Cancer Research.1999
  • 10Suzuki K,Fueyo J,Krasnykh V,Reynolds PN,Curiel DT,Alemany R.A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency[].Clinical Cancer Research.2001

共引文献46

同被引文献8

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部